Commentary and Observations from
the Medical Front Lines
Sign up to receive posts from The Exchange
CATEGORIES
Latest Allergy/Immunology Articles on PCE's The Exchange
Management of Severe T2-High Asthma
Posted By: 
Amanda Michaud, MMS, PA-C
December 04, 2020
Many patients with asthma have type 2 inflammation. Type 2 inflammation, also known as T2-high asthma, is driven by presence of interleukin (IL)-4, IL-5, IL-13, eosinophils, and allergic inflammation.
Severe, persistent asthma is classified as having symptoms most days, waking with asthma once per week or more, and having low lung function despite use of medium- to high-dose inhaled corticosteroid treatment. Type 2 inflammation should be considered if a patient has evidence of eleva... Continue Reading
Filed under: Allergy/Immunology, Pulmonary Medicine
Diagnostics in Food Allergy
Posted By: Amanda Michaud, MMS, PA-C
December 02, 2020
Food allergy is a growing public health concern and its prevalence is increasing worldwide. The most common food allergens—milk, egg, soy, wheat, peanut, t... Continue Reading
Filed under: Allergy/Immunology, Public Health
Will You Get a COVID-19 Vaccine?
Posted By: 
Lawrence Herman, DMSc, MPA, PA-C
November 27, 2020
In a post earlier this week, I wrote about public skepticism concerning COVID-19 vaccines, with some surveys showing an estimated 50-50 split in terms of whe... Continue Reading
Filed under: Allergy/Immunology, Health Policy and Trends, Infectious Diseases, Preventive Medicine, Public Health
COVID-19 Vaccine Trials: Reality Check
Posted By: Lawrence Herman, DMSc, MPA, PA-C
November 24, 2020
There is both good and bad news with respect to the ongoing COVID-19 vaccine trials. As a preface, know that approximately 90% of vaccine trials fail to lead... Continue Reading
Filed under: Allergy/Immunology, Infectious Diseases, Preventive Medicine, Public Health
Diagnosis and Management of Chronic Idiopathic Urticaria
Posted By: Amanda Michaud, MMS, PA-C
July 24, 2020
Chronic idiopathic urticaria (CIU), also called chronic spontaneous urticaria (CSU), is a condition when urticaria, or hives, are present for more than 6 wee... Continue Reading
Filed under: Allergy/Immunology, Dermatology
Why Your Patient Probably Isn’t Allergic to Penicillin
Posted By: Amanda Michaud, MMS, PA-C
July 17, 2020
Drug allergies are documented in more than 20% of electronic health records throughout the world, with antibiotic allergies being the most commonly reported.... Continue Reading
Filed under: Allergy/Immunology
Would You Volunteer to Enroll in a COVID-19 Vaccine Trial?
Posted By: 
Lawrence Herman, PA-C, MPA
July 10, 2020
There are more than 160 COVID-19 vaccines currently in development, with the University of Oxford/AstraZeneca AZD1222 vaccine (an attenuated altered adenovir... Continue Reading
Filed under: Allergy/Immunology, Infectious Diseases, Public Health
Asthma Q&A With Dr Kurtis Elward: Part 2
Posted By: 
Kurtis S. Elward, MD, MPH
June 30, 2020
PCE recently held our Series 1 Live Stream events. During the Live Streams, attendees have the chance to ask expert faculty specific questions, though we oft... Continue Reading
Filed under: Allergy/Immunology, Pulmonary Medicine
Asthma Q&A With Dr Kurtis Elward: Part 1
Posted By: Kurtis S. Elward, MD, MPH
June 26, 2020
PCE recently held our Series 1 Live Stream events. During the Live Streams, attendees have the chance to ask expert faculty specific questions, though we oft... Continue Reading
Filed under: Allergy/Immunology, Pulmonary Medicine
Measles and Immunity
Posted By: 
Ben Taylor, PA-C, PhD, DFAAPA
November 19, 2019
Measles is a highly contagious viral illness, currently targeted for eradication given the favorable biologic characteristic that humans are the only reservo... Continue Reading
Filed under: Allergy/Immunology, Infectious Diseases
Universal Influenza Vaccine Begins Phase I Clinical Trials
Posted By: 
Lawrence Herman, MPA, PA-C
April 09, 2019
The National Institutes of Health have begun the first clinical trial of an innovative universal influenza vaccine candidate. A Phase I trial will examine th... Continue Reading
Filed under: Allergy/Immunology, Health Policy and Trends, Public Health